Please login to the form below

Syndicated or dedicated sales force?

What's the difference and which is right for you?
Pharmaceutical companies commonly use outsourced sales teams to support their existing promotional efforts. Two popular options our clients use are syndicated and dedicated sales teams, but what’s the difference and which is right for you and your brand?

Ashfield were the first to introduce syndicated sales teams over 10 years ago. 
We presented syndicated sales teams as a flexible option in response to the dynamic needs of our client’s brands and promotional campaigns. Today, we continue to refine and evolve the model to ensure it responds to changing industry needs and governance. 


Dedicated sales teams can be designed, recruited and built completely to client specification
. Ashfield teams can supplement and integrate with pre-existing in-house salesforce or can be designed to be managed as the sole sales platform with your customers. 

Every brand is unique and faces its own challenges. At Ashfield, we believe there is no one size fits all approach when it comes to product promotion.

Read the full article published by Ashfield Commercial and written by Jesse Wirz, to understand the difference between syndicated and dedicated sales teams in 5 easy steps.

14th July 2016



Company Details


Contact Website

Ashfield House
Resolution Road
Ashby de la Zouch
LE65 1HW

Latest content on this profile

Ashfield wins Best Newcomer at the Pf Awards 2018
We are thrilled to announce that Zuchaela Smylie, from Ashfield, won Best Newcomer at the 2018 Pf Awards, the largest pharmaceutical sales awards in the UK. The awards ceremony took place on Thursday, 9 March at The Lancaster Hotel in London.
“It is evident that meeting face-to-face is still highly valued in the digital age”
Attending a scientific congress or meeting overtakes professional journals and publications as the educational channel of choice for Healthcare Professionals – according to findings of new study
Ashfield to present at the Orphan Drugs for Rare Diseases Summit
Ashfield has a breadth of experience with orphan drugs and we are passionate about helping to improve the lives of people living with rare diseases. We are delighted to be sponsoring and presenting at the ‘Orphan Drugs for Rare Diseases’ event 22-23 March in Berlin.
Addressing the biggest challenges for rare disease communities
Each year, Rare Disease Day takes place worldwide on the last day in February. The main objective of Rare Disease Day is to raise awareness amongst the general public, the healthcare industry and decision-makers about rare diseases and their impact on patients' lives.
Humanise is our strategic approach to healthcare communications. It’s based on the need to understand. It looks at the emotions that make us human. It examines the feelings we have as individuals. It defines the behaviours we show as people.
Ashfield launches new commercial model to improve ROI
Ashfield, part of UDG Healthcare, a global leader in providing outsourced healthcare services, has announced the launch of a pioneering new commercial model called The Ashfield Solution.